fbpx
April 26, 2023

Novel PD Drug Tops Pramipexole ER With Fewer Side Effects Novel PD Drug Tops Pramipexole ER With Fewer Side Effects

A novel experimental drug for early Parkinson’s disease (PD) yielded similar results as commercially available pramipexole extended-release (ER) but with significantly less daytime sleepiness, a new […]
April 26, 2023

FDA Gives Fast-Track Approval to New ALS Drug FDA Gives Fast-Track Approval to New ALS Drug

The FDA  has approved the first treatment that takes a genetics-based approach to slowing or stopping the progression of a rare form of ALS, the debilitating […]
April 26, 2023

‘Shocking’ Data on What’s Really in Melatonin Gummies ‘Shocking’ Data on What’s Really in Melatonin Gummies

The vast majority of melatonin gummies sold in the US may contain up to 347% more melatonin than is listed on the label, and some products […]
April 26, 2023

Novel Continuous Infusion System Promising for Parkinson’s Novel Continuous Infusion System Promising for Parkinson’s

BOSTON – A new subcutaneous system for infusing levodopa-carbidopa continuously over 24 hours to control Parkinson’s disease met its primary and secondary endpoints in a double-blind, double-dummy […]
April 25, 2023

High Dose Vitamin D and MS Relapse: New Phase 3 Data High Dose Vitamin D and MS Relapse: New Phase 3 Data

High-dose vitamin D in patients with relapsing, remitting multiple sclerosis (RRMS) does not prevent relapse, results from a randomized control trial show. However, at least one […]
April 25, 2023

Noninvasive Test in Midlife Flags Late-Onset Epilepsy Risk Noninvasive Test in Midlife Flags Late-Onset Epilepsy Risk

Noninvasive tests performed in midlife may help identify people who are at risk of late-onset epilepsy (LOE), a new study suggests. New data from the Framingham […]
April 25, 2023

Explanation Proposed for Long-COVID Symptoms in the CNS Explanation Proposed for Long-COVID Symptoms in the CNS

Editor’s note: Find the latest long COVID news and guidance in Medscape’s Long COVID Resource Center. BOSTON — The neurologic symptoms of long COVID appear to be explained […]
April 25, 2023

Novel Agent Offers Hope for Hereditary ATTR Polyneuropathy Novel Agent Offers Hope for Hereditary ATTR Polyneuropathy

The investigational agent eplontersen (Ionis Pharmaceuticals/AstraZeneca) halted neuropathy disease progression and improved neuropathy impairment and quality of life for patients with hereditary transthyretin-mediated amyloid polyneuropathy (ATTRv-PN) […]
April 24, 2023

Steroid May Benefit Some With Chronic Subdural Hematoma Steroid May Benefit Some With Chronic Subdural Hematoma

LOS ANGELES ― Previous research has led to questions concerning the value of administering the steroid dexamethasone to patients with chronic subdural hematoma before surgery. Now, […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0